Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas [Phase 2]
Phase 2 clinical trial evaluating nivolumab in Epstein-Barr virus–positive lymphoproliferative disorders and EBV-positive non-Hodgkin lympho…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials [NA]
A clinical trial update describing efforts to improve adolescent and young adult self-reported data in ECOG-ACRIN trials, with trials curren…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cell Transplant: A Pilot Study [NA]
A pilot study evaluating fecal microbiota transplantation in patients with lymphoma undergoing CAR-T therapy or allogeneic stem cell transpl…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors [NA]
Massachusetts General Hospital is conducting a clinical trial to increase resiliency among lymphoma survivors who have recently completed tr…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Survivors Uniting for Remote Guided Exercise [NA]
Clinical trial update from Colorado State University about a remote guided exercise program for cancer survivors; the study is currently rec…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship [NA]
This Massachusetts General Hospital clinical trial investigates a resilience-based intervention to improve long-term quality of life for lym…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers [NA]
A clinical trial is recruiting to test an AI-generated, personalized question prompt list designed to help patients with lymphoma or multipl…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: RGL-305+ Lymphoma + Exploratory Clinical Study [NA]
A clinical trial update describes an exploratory study of RGL-305 for lymphoma patients who have complete or partial responses after standar…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Clonal Hematopoiesis of Immunological Significance
This is a clinical trial update about clonal hematopoiesis of immunological significance (CHIS) sponsored by Assistance Publique - Hôpitaux …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]
Clinical trial update for a Phase 1-2 study of ASTX660 in subjects with advanced solid tumors and lymphomas; recruitment status is ACTIVE_NO…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: ASCT With TEAM Conditioning for Lymphoma With High Risk of CNS Relapse [Phase 2]
A Phase 2 clinical trial evaluating autologous stem cell transplantation with TEAM conditioning for lymphoma patients at high risk of centra…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation [Phase 2]
This Phase 2 clinical trial protocol investigates a post-transplant cyclophosphamide–based graft-versus-host disease prophylaxis approach in…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)
This document reports a clinical trial update for INTeRCePT 2.0 evaluating dynamic risk profiling in patients with relapsed/refractory lymph…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma [EARLY_Phase 1]
A Phase 1 clinical trial is recruiting to evaluate dietary and topical magnesium replacement or supplementation in patients with lymphoma.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma [NA]
This clinical trial update compares imaging characteristics of the uEXPLORER PET/CT scanner with conventional PET/CT in patients with lung c…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Feasibility of Intermittent Fasting During Chemotherapy [NA]
This clinical trial update describes a feasibility study evaluating intermittent fasting during chemotherapy, sponsored by the University of…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
This clinical trial update outlines a natural history study to characterize drug metabolism phenotype in patients undergoing allogeneic hema…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant [Phase 1]
A Phase 1 study evaluating the use of melphalan in lymphoma patients undergoing autologous hematopoietic cell transplantation.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Clinical Study of U29 Injection (CD30-CART) in Patients With CD30-Positive Relapsed/Refractory Lymphoma [Phase 1]
Phase 1 clinical trial evaluating U29 Injection (CD30-CART) in CD30-positive relapsed or refractory lymphoma. The study is currently recruit…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Phase 1, Open-label, Multicenter, Dose Escalation Study of IBI363 (PD1-IL2m) in Subjects With Advanced Solid Malignancies or Lymphomas [Phase 1]
Phase 1, open-label, multicenter dose-escalation study of IBI363 (PD1-IL2m) in adults with advanced solid tumors or lymphomas; trial status …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Mind-Body Medicine for the Improvement of Quality of Life in Adolescents and Young Adults Coping With Lymphoma [NA]
An update on an active, not recruiting clinical trial at MD Anderson Cancer Center testing mind-body medicine to improve quality of life for…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors [Phase 1]
A Phase 1 clinical trial update for a CD70-targeted CAR T therapy (CD70.CAR) in CD70-positive lymphoma, multiple myeloma, solid tumors, sarc…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma [NA]
An update on an active-not-recruiting MD Anderson clinical trial assessing the feasibility of combining genomics and transcriptomics for pat…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma [Phase 1, Phase 2]
This document outlines an ongoing Phase 1/2 dose-escalation and dose-expansion trial of MDX2003 in multiple lymphoma types, including Walden…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma [Phase 1, Phase 2]
This entry reports a Phase 1/2 clinical trial evaluating CBL0137 for relapsed or refractory solid tumors, including central nervous system t…